Nicholas Piramal India Limited
   
Transcript of Q1 FY04 Q&A Conference Call

For Latest Analyst Presentation on Q4 FY2008 Results
CLICK HERE

Nicholas Piramal launches India's first & only medical device to control hypertension


 
 

Nicholas Piramal signs Product Development & Licensing Agreement with DxTech

Nicholas Piramal India Limited reports Q4 FY2008 results

Nicholas Piramal India Limited acquires Anafortan and CEFI Brand Groups from Khandelwal Laboratories Pvt. Ltd.
Investor Relations

The information provided on this web site is historical content only. Such information was valid only for the date of its publication.

Google
Search WWW Search www.nicholaspiramal.com
Copyright© 2003 Nicholas Piramal India Limited